Ana Latorre studied Biology at the Universidad Autónoma de Madrid, where she also obtained her master degree in Genetics a Cellular Biology. Her work was focus on the development of different nanostructures functionalized with drugs and nucleic acids for the treatment of breast cancer and uveal melanoma.Currently, she is carrying out her PhD at IMDEA Nanociencia under the supervision of Dr. Álvaro Somoza.
Phone: +34 912998889
Eduardo García Garrido
Eduardo García Garrido studied Chemistry at the Universidad Autónoma de Madrid (2011-2015) where he also obtained his master degree in Organic Chemistry (2016) working in the synthesis of different phthalocyanines derivatives and its precursors.From February 2017, he happily started his PhD at IMDEA Nanociencia under the supervision of Dr. Álvaro Somoza.
His actual work is focused in the synthesis of linkers to control the biological activity of modified nanoparticles.
Fun facts: He is Leo, vegetarian, loves the rainy days and go climbing.
Phone: +34 912998889
Paula Milán Rois
Paula Milán Rois obtained her biology degree at the Universidad Autónoma de Madrid. She has worked with Magdalena Cañete on antineoplastic therapy based on the combination of a chemotherapeutic drug combined with a photodynamic drug. In order to internalize this treatment, she used silica nanoparticles. That was the first time she came into contact with nanomedicine.Later, she studied Biomolecules and Cell Dynamics master at the Universidad Autónoma de Madrid. During this period, she got in touch with the microRNAs and nanoparticles. Specifically, synthesis and biological characterization of spherical nucleic acids for the uveal melanoma treatment was her master’s dissertation.
Nowadays she is conducting her predoctoral studies at IMDEA Nanoscience in Álvaro Somoza’s group. Her thesis deals with the treatment and detection of uveal melanoma cancer with gold nanoparticles. Moreover, she takes part in other projects such as Duchenne Muscular Dystrophy treatment or magnetic nanoparticles for the pancreatic cancer therapy.
Ciro Rodríguez Díaz
Ciro Rodríguez studied Chemistry at the Universidad Autónoma de Madrid, where he also obtained his master degree in Organic Chemistry under the guidance of Prof. M. Ribagorda , his work was focused on 1,3-dipolar cycloaddition reactions between 2,5-diaryltetrazoles and quinones for the synthesis of fluorescent glycosylated pyrazoloquinones .
Currently he started his PhD in Organic Chemistry at IMDEA Nanociencia under the supervision of Dr. Álvaro Somoza.
Interest facts: He is an enthusiast person with an intellectual pursuit (huge geek) and likes games (mainly videogames and board games).
Demian Pardo studied Biochemistry at Universidad Autónoma de Madrid, where he also obtained his master’s degree in biotechnology. He worked as laboratory technician at ¨Instituto de Química Orgánica General¨ at the oligosaccharides and glycosystems group in Spain
Currently, he is carrying out his PhD at IMDEA Nanociencia under the supervision of Dr. Álvaro Somoza.
Nuria Lafuente Gómez
Nuria Lafuente Gómez obtained her degree in Pharmacy with honors at the Universidad Complutense de Madrid. With a collaboration scholarship in the Chemistry in Pharmaceutical Sciences Department, she worked under the guidance of Dr. Victoria Cabañas and Dr. Juan Luis Paris in the development of ceramic-hydrogel scaffolds with mesoporous silica nanoparticles loaded with antibiotics to treat infections in bone prosthetics. Currently, she is carrying out her PhD at IMDEA Nanociencia under the supervision of Dr. Álvaro Somoza.
Carmen Escalona studied Biochemistry at the Universidad Complutense de Madrid. In 2017, she obtained her Master’s degree in Biomedical Sciences at the Katholieke Universiteit of Leuven (Belgium). She carried out her Master Thesis at the Stem Cell Institute (KU Leuven), where she studied the role of the Wnt signaling pathway in the proliferation of cancer cells under the guidance of Prof. Lluis Viñas. In 2018 she joined IMDEA Nanoscience as a PhD student.
Rama Prajapati obtained her degree in Pharmacy from Kathmandu University, Nepal. With the Danish Government scholarship, she did her Msc. in Pharmaceutical sciences from University of Copenhagen, Denmark. For her master thesis, she worked under the supervision of Associate professor Anan Yaghmur for the preparation and characterization of lipid nanoparticles for arthritis and cancer therapy.
Currently, she is carrying out her PhD with la Caixa fellowship, at IMDEA Nanociencia under the supervision of Dr. Alvaro Somoza.
Phone: +34 648918909
María López Valls
María López studied Biotechnology at Universidad de Murcia. In 2017, she did an internship in the biochemistry department of Technische Universität Dresden. There, she worked in a project titled “Production of new bioactive compounds by plants and bacteria using new and improved halogenases” under the supervision of Dr Karl-Heinz van Pée and Dr Eugenio Patallo. In 2018, she started her Master on Advanced Biomedical Sciences at the University of the West of Scotland (United Kingdom). During her Master thesis, she studied the role of different isoforms of RUNX1 in Acute Myeloid Leukemia.
Currently and since 2019, she is carrying out her PhD at IMDEA Nanociencia under the supervision of Dr Begoña Sot.
Catarina Castanheira was born in Lisbon (Portugal) in 1994. In 2012 she moved from Braga (Portugal) to Porto (Portugal) to enroll the Integrated Master in Bioengineering at the University of Porto. In 2015 she conducted a training period in REQUIMTE Research Lab (Chemistry and Biochemistry Department, Faculty of Sciences, University of Porto), in the group of Dr. Maria Rangel, which involved the use of pyridinone‑dansyl complexes as sensors for metal ions. In 2016 she conducted a 5 month internship at IMDEA Nanociencia, in the group of Dr. Álvaro Somoza, where she developed nanobiosensors based on gold nanoparticles for the detection cancer‑related miRNAs. In 2017, Catarina started her Master Dissertation project at the Nanomedicines & Translational Drug Delivery group in i3S/INEB (Institute of Investigation and Innovation in Heath / Institute of Biomedical Engineering), University of Porto, supervised by Dr. José das Neves and Dr. Bruno Sarmento. There she developed functionalized polymeric nanoparticles for the topical delivery of anti-HIV microbicides. Catarina obtained her MSc Degree in Bioengineering – Molecular Biotechnology in October 2017 and after that she continued her work at the Nanomedicines & Translational Drug Delivery group. In March 2018, driven by her interest in inorganic nanostructures for diagnostics and therapy, she came back to IMDEA as a visiting student. In April 2019, she started to work as technician in the RENIM Project to modify magnetic nanoparticles with different molecules for diagnostics and imaging. Since September 2019, she is carrying out her PhD, with an AECC fellowship, under the supervision of Dr. Álvaro Somoza and Dr. Milagros Castellanos. Her work focuses on the use of gold nanoparticles for cancer diagnosis and gene therapy.
Phone: +34 912998889 email@example.com